Astragalus polysaccharides exerts anti‐infective activity by inducing human cathelicidin antimicrobial peptide LL‐37 in respiratory epithelial cells. (19th April 2018)

• Record Type: Journal Article
• Authors: Zhao, Lin; Tan, Shuai; Zhang, Hai; Liu, Peng; Tan, Yu‐Zhu; Li, Jia‐Chuan; Jia, Da; Shen, Xiao‐Fei
• Is Part Of: Phytotherapy research. Volume 32:Number 8(2018)
• Page Start: 1521
• Page End: 1529
• Publication Date: 2018-04-19
• Subjects: anti‐infective activity -- astragalus polysaccharides -- human cathelicidin antimicrobial peptide LL‐37 -- NF‐κB signaling -- p38 MAPK and JNK signaling; Materia medica, Vegetable -- Periodicals; Botany, Medical -- Periodicals; Medicinal plants -- Periodicals; Plant Extracts -- therapeutic use -- Periodicals; Plants, Medicinal -- Periodicals; 581.634
• DOI: 10.1002/ptr.6080
• Languages: English
• ISSNs: 0951-418X

Abstract

Abstract : Astragalus polysaccharides (APS), one of the major active components in Astragalus membranaceus, is an effective immunomodulator used in the treatment of immunological diseases in China. However, the anti‐infective action and mechanism of APS is not fully known. In the present study, we found that APS induced the expression of human cathelicidin antimicrobial peptide LL‐37, a key host anti‐infective molecule, in both mRNA and protein levels in respiratory epithelial cells HBE16 and A549. Furthermore, the lysate and supernatant from APS‐treated HBE16 cells both exhibited an obvious antibacterial action, which was partially neutralizated by LL‐37 monoclonal antibody. In addition, APS also significantly elevated the phosphorylation of p38 MAPK and JNK and caused the degradation of IκBα. Specific inhibitors of p38 MAPK, JNK, or NF‐κB obviously abolished APS‐induced LL‐37 synthesis and antibacterial activity, respectively. Taken together, our results confirmed the enhancement of APS on LL‐37 induction and antibacterial action in respiratory epithelial cells, which may be attributed to activation of p38 MAPK/JNK and NF‐κB pathways. Furthermore, these results also supported the clinical application of APS in the treatment of infectious diseases.